The purpose of this study was to investigate the clinical efficacy and safety of a fixed-dose combination of mometasone furoate/formoterol fumarate ( MF/F ) administered via a metered-dose inhaler in subjects with moderate-to-very severe chronic obstructive pulmonary disease ( COPD ) .
